NEW YORK, Dec. 20, 2021 /PRNewswire/ — Summus Global, the leading virtual specialist platform, announces Mary Mulcare, MD, Clinical Assistant Professor of Emergency Medicine, Weill Cornell, and Chief Medical Officer, Summus Global, is leading a new pathway in teaching pre-clinical medical students about telemedicine through virtual platforms. To overcome pandemic-based in-person learning, medical students successfully shadowed Dr. Mulcare and leading emergency medicine (EM) physicians at Weill Cornell Medicine’s Healthcare Leadership and Management (HLM) Scholars Program. Students gained enhanced experience through a virtual shadowing model of emergency department (ED) patient care and telemedicine patient visits.
Dr. Mulcare is a leader in developing new platforms for delivering virtual care, including Summus Global’s virtual specialist platform.
Who: |
Mary Mulcare, MD, Clinical Assistant Professor of Emergency Medicine, Weill Cornell; Chief Medical Officer, Summus Global |
When: |
Available for Media Interviews |
Where: |
Mary Ann Liebert, Inc. Publication, Telemedicine Reports: |
Details: |
Media interviews will discuss: |
|
About Summus Global
Summus Global, the leading virtual specialist platform, empowers families by providing access to a network of 4,000+ top specialists across 48 leading hospitals – within days, from anywhere in the world. The Summus model sets a new standard for speed of access to high-quality medical expertise and drives industry-leading engagement with employers. Pioneering the future of corporate health benefits, Summus Global partners with companies across the country to create an elevated healthcare experience for their employees and to support better, cost-efficient outcomes across all health questions and stages of care.
View original content:https://www.prnewswire.com/news-releases/telemedicine-reports-virtual-clinical-shadowing-for-pre-clinical-medical-students-in-an-emergency-medicine-based-leadership-course-301448588.html
SOURCE Summus Global
NORTHAMPTON, MA / ACCESSWIRE / June 12, 2024 / Gilead SciencesLuciana Preger credits being exposed…
CHESTNUT HILL, MA / ACCESSWIRE / June 12, 2024 / Nava Health, a leader in…
Investor webcast on or before July 23 will include updates on Jaguar's cancer supportive care…
New AI-driven technology integration marks a first in the U.S., enhancing patient access to specialized…
TORONTO, ON / ACCESSWIRE / June 12, 2024 / Theralase® Technologies Inc. ("Theralase®" or the…
Targeted protein degradation (TPD*) technologies have demonstrated the potential to produce novel treatment approaches Surrozen’s…